Search Results - "PAPENDICK, U"

Efficacy trial of topically administered interferon gamma-1 beta gel in comparison to laser treatment in cervical intraepithelial neoplasia by Schneider, A, Grubert, T, Kirchmayr, R, Wagner, D, Papendick, U, Schlunck, G

“…Dose dependent response of cervical intraepithelial neoplasia (CIN) to topically administered interferon (IFN) gamma was assessed and compared with…”
Get full text

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate: a randomized multicenter trial by PORZSOLT, F, MESSERER, D, PAPENDICK, U, SCHREML, W, HAUTMANN, R, GOTTWALD, A, SPARWASSER, H, STOCKAMP, K, AULITZKY, W, MOORMANN, J. G, SCHUMACHER, K, RASCHE, H

“…The response rates in metastatic renal cell cancer (RCC) after chemotherapy, hormonal treatment, or immunotherapy rarely exceed 15%. Recently, interferon alpha…”
Get full text

Deficient IFN alpha production in hairy cell leukemia by Porzsolt, F, Janik, R, Heil, G, Brudler, O, Raghavachar, A, Scholz, S, Papendick, U, Heimpel, H

“…Since the application of low doses of IFN-alpha is necessary to maintain remissions in Hairy Cell Leukemia (HCL) it is of interest whether peripheral blood…”
Get more information

Human papillomavirus infections in women with and without abnormal cervical cytology by de Villiers, E M, Wagner, D, Schneider, A, Wesch, H, Miklaw, H, Wahrendorf, J, Papendick, U, zur Hausen, H

“…9295 smears, obtained from women attending three gynaecological hospitals for routine screening, were examined for human papillomavirus (HPV) types 6 and 11…”
Get more information

Efficacy of Interferons on Bowenoid Papulosis and Other Precancerous Lesions by Gross, Gerd, Roussaki, Angelika, Papendick, Uwe

“…Preliminary results of an open randomized trial of recombinant interferon gamma in patients suffering from bowenoid papulosis are described. Recombinant…”
Get full text

Efficacy trial of topically administered interferon gamma-1? gel in comparison to laser treatment in cervical intraepithelial neoplasia by Schneider, A., Grubert, T., Kirchmayr, R., Wagner, D., Papendick, U., Schlunck, G.

Get full text

Interferon treatment of human genital papillomavirus infection: importance of viral type by Schneider, A, Papendick, U, Gissmann, L, De Villiers, E M

“…Eighteen women and 6 of their male sexual partners with lower genital tract infections caused by various human papillomavirus (HPV) types were treated with…”
Get more information

Efficacy of interferons on bewenoid papulosis and other precancerous lesions by GROSS, G, ROUSSAKI, A, PAPENDICK, U

Get full text

Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia by HO, A. D, GROSMAN, M, TRÜMPER, L, PEZZUTTO, A, PRALLE, H, BOEDEWADT-RADZUN, S, PAPENDICK, U, GÖD, B, ZWINGERS, T, HUNSTEIN, W

“…Plasma levels of soluble T-suppressor/cytotoxic antigen (sCD8) were measured at diagnosis or before systemic treatment in 69 patients with hairy cell leukemia…”
Get full text

Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia by Ho, AD, Grossman, M, Trumper, L, Pezzutto, A, Pralle, H, Boedewadt-Radzun, S, Papendick, U, God, B, Zwingers, T, Hunstein, W

“…Plasma levels of soluble T-suppressor/cytotoxic antigen (sCD8) were measured at diagnosis or before systemic treatment in 69 patients with hairy cell leukemia…”
Get full text

Alpha 2 -interferon therapy in metastasizing malignant melanoma by Landthaler, M, Geyer, C, Papendick, U, Braun-Falco, O

“…Low doses of recombinant alpha 2-interferon were administered to 20 patients with stage III malignant melanoma. Dosage was 2.5 million IU intramuscularly daily…”
Get more information

Pork intake and human papillomavirus-related disease by Schneider, A, Morabia, A, Papendick, U, Kirchmayr, R

“…Clinical and ecological evidence supporting an association between human papillomavirus (HPV)-related tumors and dietary factors are presented. Abstinence from…”
Get more information

A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy by Pralle, H, Zwingers, T, Boedewadt, S, Bross, K, Dörken, B, Gamm, H, Ho, A D, Parwaresch, R M, Schmitz, N, Papendick, U

“…Our multicenter study on the treatment of hairy cell leukemia (HCL) started in December 1984 and the present data cover the time up to June 30, 1986…”
Get more information

Deficient IFN? production in hairy cell leukemia by Porzsolt, F., Janik, R., Heil, G., Brudler, O., Raghavachar, Ar, Scholz, S., Papendick, U., Heimpel, H.

Get full text

Penetration of the tympanum by active substances (author's transl) by Henschel, E, Papendick, U, Sell, R

“…In a specially designed animal model the penetration of glucocorticoid and oxytetracycline through the intact tympanic membrane was studied. Dogs were…”
Get more information

Contribution to the modern drug therapy of various forms of glaucoma by Papendick, U, Räppe, S

Get more information

Low-dose human recombinant interferon-α-2c ARG (Hu-rIFN-α) in hairy cell-leukemia (HCL): design, recruitment and first observations in a prospective randomized multicenter trial by Pralle, H., Dörken, B., Parwaresch, R. M., Zwingers, T., Bross, K., Gamm, H., Bödewadt, S., Bartels, H., Böger, M., Bremer, K., Enmrich, H., Euler, H., Fischer, T., Fuhr, H., Ganser, A., Goldmann, B., Hartlapp, J., Hayungs, J., Ho, A. D., Kabelitz, K., Kraft, J., Müller, E. U., Neubauer, A., Nowicki, L., Pflüger, K., Schmidt, H., Schmidt, W., Papendick, U.

Get full text

Successful treatment of condylomata acuminata and bowenoid papulosis with subcutaneous injections of low-dose recombinant interferon-alpha by Gross, G, Roussaki, A, Schöpf, E, De Villiers, E M, Papendick, U

Get more information

The local anesthetic effect of NA872-containing eyedrops by Klier, K F, Papendick, U

Get more information

Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy by Pralle, H, Zwingers, T, Boedewadt, S, Bross, K, Dörken, B, Gamm, H, Ho, A D, Parwaresch, R M, Schmitz, N, Papendick, U

“…Within less than 14 months of recruitment 32 centers enrolled 97 patients in a multicenter trial for low-dose treatment of hairy cell leukemia (1.2 X 10(6)…”
Get more information